U.S. Pharmacist Weekly News

November 29, 2017

Children Still Getting Codeine After Procedures, Despite
FDA Warning

A warning from the FDA has stemmed the tide of codeine prescribing to children after tonsillectomy or adenoidectomy, but the dangerous practice continues, a new study warns. Find out what researchers recommend instead.

Meta-Analysis: No Benefit for Universal BP Treatment Below 140 mm HG
How high is too high when determining at what point to treat hypertension? A new Swedish review goes against new guidelines, finding that treating healthy people for systolic blood pressure below 140 does not reduce death or cardiovascular disease. Here are the details.

Once Opioid Treatment Begins, Naltrexone as Effective as Buprenorphine-Naloxone
Treating patients with naltrexone can be difficult because patients must detoxify before using the drug. Once that is achieved, however, the opioid antagonist appears to be as safe and effective as buprenorphine, an opioid agonist, according to a new study. Here is more information that researchers provided about the differences between the drugs and how they should be used.

Older IBD Patients Less Likely to Be Prescribed Cutting-
Edge Medications

A larger-than-expected percentage of new inflammatory bowel disease (IBD) patients are older than age 60 years, according to a new study pointing out that those patients were more likely to be treated with older cortisone drugs instead of newer agents targeting the immune system. What else did researchers determine about the demographics of IBD and why newer drugs were less often to be used in older patients?

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App